ESPR — Esperion Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapTurnaround

Annual balance sheet for Esperion Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	259	167	82.2	145	168
Net Total Accounts Receivable
Net Total Receivables	22.9	33.7	48.5	80.1	140
Total Inventory
Prepaid Expenses
Total Current Assets	329	247	201	338	463
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.56	1.2	4.67	5.77	3.26
Net Intangible Assets
Other Long Term Assets
Total Assets	382	248	206	344	466
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	73.4	92.3	156	246	301
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	579	572	661	733	768
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-197	-324	-455	-389	-302
Total Liabilities & Shareholders' Equity	382	248	206	344	466
Total Common Shares Outstanding